Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV L-citrulline in sickle cell pain crisis or acute chest syndrome
NCT02697240Phase 1Completed
- Sponsor
- University of Mississippi Medical Center
- Start
- Feb 2016
- Primary completion
- Apr 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of citrulline in sickle cell disease (SCD), sponsored by University of Mississippi Medical Center. Primary endpoints: Number of Participants With Adverse Events at 30 days and Plasma Citrulline Level at 48 hours. Started Feb 2016; status: completed.
02
Drugs
citrulline
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT02697240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02697240.